CARI Health, Inc.

Based in California, US, and founded in 2015, CARI Health, Inc. operates as a developer of wearable remote medication monitors. In May 2022, the firm raised USD 800,000 in seed funding led by investor San Diego Angel Conference, with participation from other investors Chemical Angel Network, Medical Devices of Tomorrow, NuFund Venture Group, and The Cove Fund. The firm, as of January 2023, is led by its CEO, Patrik Schmidle.

The company (as of January 2023) is developing a pain-free, small, and wireless sensors-based remote medication monitoring (RMM) patch which can be worn on the patient’s skin that continuously sends data about medication levels in the patient’s body to the CARI Cloud. The company’s product work in 3 steps, first the product is integrated with the clinician's prescription, and remote monitoring has been set up, then the patient takes medicines and wears RMM, and then the product monitors the medication level and sends alerts to clinicians, patients, and family members if medication is not in the desired range. The company plans to utilize its May 2022 funding to complete in-patient human clinical studies for its RMM device and prepare for regulatory approvals with Food and Drug Administration in the US. The company also plans to introduce its device to the patients being treated with medications for opioid use disorder (MOUD), first.